Tectonic Therapeutic, Inc.
Biotechnology
Healthcare
TECX
14.73 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
19.93
52 week high
54.84
high
20.75
52 week low
14.67
low
19.57
growth
13.12 %
previous Close
20.17
P/E ratio
-17
market cap
265 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-17.72 M
-39.82 %
eps
-1.20 %
72.28 %
eps surprise
-46.70 %
net profit margin
-1771700000.00 %
0.00 %
operating incoming
-19.64 M
-71.94 %
net change in cash
-26.03 M
-15.00 %
cash on hand
159 M
-14.06 %
cost of revenue
0.00 %
top top